Affymetrix Earnings Conference Call (Q3 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 21 Calls Today's Calls

Call Details Affymetrix Earnings Conference Call (Q3 2009) Wed, Oct 21, 2009, 5:00 pm Eastern Listen to the archived event audio About Affymetrix (NasdaqGS:AFFX) Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The company offers integrated GeneChip microarray platform that includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. Its products are used in various applications, including the monitoring of gene or exon expression levels and investigation of genetic variation. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers; government research laboratories; private foundation laboratories; and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East, and the Asia Pacific regions, including the People’s Republic of China. It has collaboration partnerships with Caliper Life Sciences, CapitalBio Corporation, Life Technologies, Pathwork Diagnostics, PreAnalutiX GmbH, and Qiagen GmbH. The company was founded in 1991 and is headquartered in Santa Clara, California. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings